Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, Japan.
Department of Gastroenterology, Yokkaichi Hazu Medical Center, Japan.
Intern Med. 2023 Nov 15;62(22):3347-3353. doi: 10.2169/internalmedicine.1298-22. Epub 2023 Apr 7.
Pancreatic mixed neoplasms are very rare. We herein report a unique case of pancreatic mixed acinar-neuroendocrine-ductal carcinoma with trilineage differentiation. The patient was an 83-year-old woman referred to our hospital due to anemia and a pancreatic mass. Contrast-enhanced computed tomography revealed a 60-mm mass in the pancreas. Subtotal stomach-preserving pancreaticoduodenectomy was performed. The postoperative pathological diagnosis was mixed acinar-neuroendocrine-ductal carcinoma. Postoperative chemotherapy was conducted according to the adenocarcinoma and neuroendocrine carcinoma protocols. The patient died 26 months postoperatively. Choosing appropriate chemotherapy for mixed neoplasms is difficult. Cancer gene panel testing, if possible, may support the choice of therapeutic agents.
胰腺混合性腺神经内分泌癌非常罕见。本文报告 1 例罕见的胰腺混合性腺神经内分泌癌伴三系分化病例。患者为 83 岁女性,因贫血和胰腺肿块就诊。增强 CT 显示胰腺有 60mm 大小肿块。行保留全胃胰十二指肠切除术。术后病理诊断为混合性腺神经内分泌癌。术后根据腺癌和神经内分泌癌方案进行化疗。患者术后 26 个月死亡。混合性肿瘤的化疗选择较为困难。如果可能,进行癌症基因panel 检测可能有助于选择治疗药物。